You are here: Industry Insights > CCRM

News List

CellCAN and CCRM Partner to Launch CATTI contractpharma
July 30, 2021
The fast growth of cell and gene therapies has made it difficult for the global industry to keep up with talent requirements. The volume of clinical trials around the world—approximately 1,200 at this time1—puts pressure on manufacturers to scale-up ...
CCRM Enters Regenerative Medicine Partnerships contractpharma
June 02, 2021
CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies, is partnering with several Canadian and international institutions to advance regenerative medicine inventions, including: McGill ...
CCRM and Amgen Partner to Advance Emerging Medical Innovations contractpharma
May 06, 2021
New regenerative medicine discoveries, including cell and gene therapies, will never reach patients without access to the funding, expertise and other specialized support that are required to move along the commercialization pathway.
CCRM, MIP Partner to Build Biomanufacturing Campus contractpharma
November 16, 2020
Aims to establish CDMO ops focused on regenerative medicine-based technologies and cell and gene therapies.
panCELLa, CCRM Collaborate to Benefit Academia and Industry contractpharma
April 22, 2020
New iPSC master cell banks to accelerate development of novel cell therapies.
Avectas, CCRM Enter Cell Therapy Tie-up contractpharma
March 04, 2020
Collaboration to accelerate development of novel technology for cell therapies.